An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
Romain Iaxx,1 Felix Lefort,1,2 Charlotte Domblides,1– 3 Alain Ravaud,1,2 Jean-Christophe Bernhard,2,4 Marine Gross-Goupil1 1Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France; 2Bordeaux University, Bordeaux, France; 3ImmunoConcEpt, CNRS UMR 5164, Bord...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2022-06-01
|
| Serija: | Therapeutics and Clinical Risk Management |
| Teme: | |
| Online pristup: | https://www.dovepress.com/an-evaluation-of-cabozantinib-for-the-treatment-of-renal-cell-carcinom-peer-reviewed-fulltext-article-TCRM |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|